Has Jacob Johnson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,027 in general payments to Jacob Johnson, MD across 49 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacob Johnson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacob Johnson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacob Johnson, MD

Otolaryngology · San Francisco, CANPI 1457300477

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by 3nt Medical at 55.5% of the total. Reporting peaked in 2020 at $8,420 and has fallen 96.9% since, to $261 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,027in general payments, 2019–2025

Across 49 payments — averaging $225.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

3nt Medical$6K
Medtronic$4K
Smith+Nephew$455
Regeneron Healthcare Solutions, Inc.$88
GSK$58
Novartis$57
plus $222 from 7 others

$61,698in research payments, 2019–2025

Across 28 payments — averaging $2203.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$32K
Intersect ENT, Inc.$17K
Arrinex, Inc.$11K
Medtronic$2K

What the payments were for

Consulting fees$6,00054%
Speaking & faculty fees$2,92427%
Travel & lodging$9639%
Food & beverage$1,14010%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
3nt Medical	2	$6,123
Medtronic(2 entities)	13	$4,024
Smith+Nephew	18	$455
Regeneron Healthcare Solutions, Inc.	3	$88
GSK	2	$58
Novartis	2	$57
Integra Lifesciences Corporation	2	$53
Optinose US, Inc.	2	$49
Sanofi	1	$29
Stryker	1	$29
Aerin Medical Inc.	1	$29
Intersect ENT, Inc.	1	$21
Acclarent, Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NUVENT$1,250
StealthStation$866
TULA$115

How this compares

$11,027 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024

$375,085

Medicare patients

1,592

Services billed

3,969

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	132	$3,220
Azelastine Hcl	74	$2,182
Ofloxacin	22	$822
Cefdinir	27	$602
Fluticasone Propionate	44	$500
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	59	$403
Clotrimazole	11	$346
Mupirocin	56	$292
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	13	$261
Mometasone Furoate	11	$230
Prednisone	61	$162
Montelukast Sodium	11	$156
Azithromycin	15	$89
Methylprednisolone	14	$55
Gabapentin	12	$51

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Francisco

Jolie ChangSan Francisco$52K
Herbert DedoSan Francisco$45K
Barry BaronSan Francisco$37K
Clark RosenSan Francisco$23K
Andrew MurrSan Francisco$22K
Brian WeeksSan Diego$924K
Randall OwRoseville$613K
Amir MoradiVista$389K
Keith BlackwellLos Angeles$349K
Kalpna DurairajSun Valley$348K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →